Teva Wins Patent Dispute with Watson
According to the Associated Press, Teva Pharmaceutical Industries has won a patent dispute against Watson Pharmaceuticals Inc. over the contraceptive Seasonique. The company said the U.S. District Court for the District of Nevada granted the company''s motion for summary judgement. Watson was trying to make a generic version of the drug before the patent expired in 2024. Teva still has ongoing patent disputes over the drug with Mylan Inc. and Lupin Ltd.